Halda-n’ to your hat for this part of the Tour de Connecticut. 🤠 We cruised down the Farmington Canal Trail from Southington to New Haven, just in time for our meeting with Halda Therapeutics, a biotech company developing RIPTAC™ therapeutics, a new class of precision medicines to defeat cancer. Chief Scientific Officer Kat Kayser-Bricker filled us in on the science behind Halda’s novel therapeutic mechanism and gave us a tour of the office and lab spaces. 🔬 We look forward to hearing more exciting news from this team in the future.#tourdect